Suppr超能文献

P-糖蛋白不参与KBv200细胞中抗Fas/Fas诱导的凋亡途径。

P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.

作者信息

Wu Qiu-Liang, Wu Xing-Ping, Liang Yong-Ju, Chen Li-Ming, Ding Yan, Fu Li-Wu

机构信息

Department of Pathology, Cancer Center, Sun Yat-Sen University, Guangzhou 510060, Guangdong Province, China.

出版信息

World J Gastroenterol. 2005 Jun 21;11(23):3544-8. doi: 10.3748/wjg.v11.i23.3544.

Abstract

AIM

To verify whether P-glycoprotein (P-gp) could induce cell resistance to apoptosis by inhibiting caspase-8 and caspase-3.

METHODS

Human KB cells, either drug-sensitive or with multidrug resistance (MDR) phenotype caused by overexpression of P-gp (KBv200 cells), were treated with anti-Fas (CH-11 monoclonal antibody) to induce apoptosis. Cytotoxicity was detected by MTT assay. Symptoms of cell death were assessed by morphological observation after Hoechst33258 staining, activation of caspase-8 and caspase-3 was measured by Western blotting.

RESULTS

Compared with KB cells, the resistance of KBv200 cells to VCR (vincristine) was about 51-fold higher. Anti-Fas (CH-11) induced cytotoxicity and apoptosis in both sensitive KB cells and MDR phenotype KBv200 cells. The IC50 of CH-11 in KB cells was similar to that in KBv200 cells. CH-11 induced similar apoptotic rates in both KB cells and KBv200 cells, which could be classified as caspase-dependent apoptotic pathway. Verapamil (VRP) did not affect CH-11-mediated apoptosis in KBv200 cells.

CONCLUSION

Expression of P-glycoprotein does not induce resistance to caspase-8 and -3 activation or anti-Fas-induced cell apoptosis.

摘要

目的

验证P-糖蛋白(P-gp)是否可通过抑制半胱天冬酶-8和半胱天冬酶-3来诱导细胞抗凋亡。

方法

用抗Fas(CH-11单克隆抗体)处理人KB细胞(对药物敏感的细胞以及因P-gp过表达导致具有多药耐药(MDR)表型的细胞(KBv200细胞))以诱导凋亡。通过MTT法检测细胞毒性。经Hoechst33258染色后通过形态学观察评估细胞死亡症状,通过蛋白质印迹法检测半胱天冬酶-8和半胱天冬酶-3的激活情况。

结果

与KB细胞相比,KBv200细胞对长春新碱(VCR)的耐药性高约51倍。抗Fas(CH-11)在敏感的KB细胞和具有MDR表型的KBv200细胞中均诱导细胞毒性和凋亡。CH-11在KB细胞中的半数抑制浓度(IC50)与在KBv200细胞中的相似。CH-11在KB细胞和KBv200细胞中诱导的凋亡率相似,这可归类为半胱天冬酶依赖性凋亡途径。维拉帕米(VRP)不影响CH-11介导的KBv200细胞凋亡。

结论

P-糖蛋白的表达不会诱导对半胱天冬酶-8和-3激活或抗Fas诱导的细胞凋亡产生耐药性。

相似文献

1
P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.
World J Gastroenterol. 2005 Jun 21;11(23):3544-8. doi: 10.3748/wjg.v11.i23.3544.
2
The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death.
Cytometry. 2001 Mar 1;43(3):189-94. doi: 10.1002/1097-0320(20010301)43:3<189::aid-cyto1048>3.0.co;2-w.
5
Drug resistance does not correlate with resistance to Fas-mediated apoptosis.
Leuk Res. 2001 Jan;25(1):69-75. doi: 10.1016/s0145-2126(00)00085-0.
7
P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
Cancer Chemother Pharmacol. 2004 Feb;53(2):179-85. doi: 10.1007/s00280-003-0705-x. Epub 2003 Oct 3.

引用本文的文献

本文引用的文献

1
Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
Curr Med Chem Anticancer Agents. 2004 Jan;4(1):43-52. doi: 10.2174/1568011043482197.
2
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Cancer Chemother Pharmacol. 2004 Apr;53(4):349-56. doi: 10.1007/s00280-003-0742-5. Epub 2003 Dec 10.
3
Anticancer therapy targeting the apoptotic pathway.
Lancet Oncol. 2003 Dec;4(12):721-9. doi: 10.1016/s1470-2045(03)01277-4.
4
5
Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?
Cancer Biol Ther. 2003 Sep-Oct;2(5):477-90. doi: 10.4161/cbt.2.5.450.
6
Strategies for reversing drug resistance.
Oncogene. 2003 Oct 20;22(47):7512-23. doi: 10.1038/sj.onc.1206951.
8
The proteasome: structure, function, and role in the cell.
Cancer Treat Rev. 2003 May;29 Suppl 1:3-9. doi: 10.1016/s0305-7372(03)00081-1.
9
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.
Drug Resist Updat. 2003 Apr;6(2):71-84. doi: 10.1016/s1368-7646(03)00005-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验